Year |
Citation |
Score |
2012 |
Simpson NE, Tryndyak VP, Pogribna M, Beland FA, Pogribny IP. Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype. Epigenetics. 7: 1413-20. PMID 23117580 DOI: 10.4161/epi.22713 |
0.403 |
|
2012 |
Simpson NE, Tryndyak VP, Beland FA, Pogribny IP. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression. Breast Cancer Research and Treatment. 133: 959-68. PMID 22101407 DOI: 10.1007/s10549-011-1871-x |
0.351 |
|
2012 |
Simpson NE, Gertz J, Imberg K, Myers RM, Garabedian MJ. Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 26: 194-202. PMID 22074947 DOI: 10.1210/Me.2011-1068 |
0.301 |
|
2010 |
Simpson NE, Lambert WM, Watkins R, Giashuddin S, Huang SJ, Oxelmark E, Arju R, Hochman T, Goldberg JD, Schneider RJ, Reiz LF, Soares FA, Logan SK, Garabedian MJ. High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Research. 70: 8446-56. PMID 20847343 DOI: 10.1158/0008-5472.Can-10-1590 |
0.71 |
|
2010 |
Chong MM, Simpson N, Ciofani M, Chen G, Collins A, Littman DR. Epigenetic propagation of CD4 expression is established by the Cd4 proximal enhancer in helper T cells. Genes & Development. 24: 659-69. PMID 20360383 DOI: 10.1101/Gad.1901610 |
0.316 |
|
2008 |
David G, Grandinetti KB, Finnerty PM, Simpson N, Chu GC, Depinho RA. Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proceedings of the National Academy of Sciences of the United States of America. 105: 4168-72. PMID 18332431 DOI: 10.1073/Pnas.0710285105 |
0.351 |
|
2006 |
David G, Dannenberg JH, Simpson N, Finnerty PM, Miao L, Turner GM, Ding Z, Carrasco R, Depinho RA. Haploinsufficiency of the mSds3 chromatin regulator promotes chromosomal instability and cancer only upon complete neutralization of p53. Oncogene. 25: 7354-60. PMID 16767157 DOI: 10.1038/Sj.Onc.1209734 |
0.489 |
|
Show low-probability matches. |